Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.48 |
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
| ▸ | MMP9 | P14780 | 1/20 | 0.48 |
| ▸ | MMP14 | P50281 | 1/20 | 0.48 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.44 |
| ▸ | MAOB | P27338 | 2/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
| ▸ | PTPRZ1 | P23471 | 1/20 | 0.41 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5635 | 0.90 | MMP2 (0.51) | MMP2MMP9MMP14ADAM17FFAR1 | |
| SCHEMBL6211 | 0.89 | MAOB (0.57) | MMP2MMP9ADAM17FFAR1FFAR4 | |
| SCHEMBL6157 | 0.85 | PARP10 (0.43) | FFAR1PTPRZ1PARP10 | |
| SCHEMBL5796 | 0.84 | MAOB (0.46) | ADAM17FFAR1MAOBPARP10 | |
| SCHEMBL6072 | 0.78 | LMNA (0.52) | — | |
| SCHEMBL11898792 | 0.78 | ADAMTS4 (0.48) | CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL5812 | 0.78 | MMP1 (0.47) | MMP1MMP2MMP9MMP14ADAM17 | |
| SCHEMBL11899992 | 0.77 | PARP10 (0.48) | FFAR1PARP10 | |
| SCHEMBL6011 | 0.76 | CA12 (0.46) | MMP1MMP9ADAM17CYP19A1 | |
| SCHEMBL12048 | 0.74 | ACACB (0.47) | FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2488489-A2 | C-LINKED HYDROXAMIC ACID DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS | Pfizer Inc. (US) | 2012-08-22 | — | — | EP | disclosed |
| WO-2011045703-A2 | C-LINKED HYDROXAMIC ACID DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS | PFIZER INC. (US) | 2011-04-21 | — | — | WO | disclosed |